These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Thyrotrophin response to thyrotrophin-releasing hormone in ophthalmic Graves' disease: correlation with other aspects of thyroid function, thyroid suppressibility and activity of eye signs. Ormston BJ, Alexander L, Evered DC, Clark F, Bird T, Appleton D, Hall R. Clin Endocrinol (Oxf); 1973 Oct; 2(4):369-76. PubMed ID: 4128973 [No Abstract] [Full Text] [Related]
25. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients. Banovac K, Zakarija M, McKenzie JM, Witte A, Sekso M. J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561 [Abstract] [Full Text] [Related]
26. [Clinical evaluation of the thyroid gland function based on T3, T4 and TSH activity and histopathological changes in various types of goiter]. Puchalski Z, Piotrowski Z, Chyczewski L, Orłowski K. Pol Przegl Chir; 1980 Mar; 52(3):205-10. PubMed ID: 6893079 [No Abstract] [Full Text] [Related]
27. The natural history of hyperthyroidism due to Graves' disease in remission: sequential studies of pituitary-thyroid regulation and various serum parameters. Gardner DF, Utiger RD. J Clin Endocrinol Metab; 1979 Sep; 49(3):417-21. PubMed ID: 112107 [No Abstract] [Full Text] [Related]
29. [Changes in thyroid function expressed by the calculation of the area under TRH-TSH curve]. Herrera JD, Sartorio GC, Soto RJ. Medicina (B Aires); 1987 Sep; 47(5):464-70. PubMed ID: 3144640 [No Abstract] [Full Text] [Related]
31. Influence of increasing iodine intake on thyroid function in euthyroid and hyperthyroid states. Emrich D, Karkavitsas N, Facorro U, Schürnbrand P, Schreivogel I, Schicha H, Dirks H. J Clin Endocrinol Metab; 1982 Jun; 54(6):1236-41. PubMed ID: 6804478 [No Abstract] [Full Text] [Related]